Monday , October 23 2017
Home / Letter From The Editor / Editor’s Note, SGLT-2 Inhibitor Special Edition, December 2014

Editor’s Note, SGLT-2 Inhibitor Special Edition, December 2014

Merry Christmas, Happy Chanukah, and Happy New Year!

I was cleaning out some old diabetes slide presentations from 2007-2010 from my computer and I happened to open a few of them to make sure I wasn’t missing any good slides before I deleted them. There were two that were patient-focused and both of them discussed the defects that occur during the development of diabetes. The first one only talked about the liver, pancreas, muscles, and fat, and the defects that can occur in these organs. The other slide presentation included the GLP-1 analogs and the idea that natural GLP-1 production has decreased by the time of diagnosis.

This year we have had the blossoming of the SGLT-2 inhibitors and this has caused many of us to revamp our presentations. I have had to go back and change slides once again as it was necessary to find a picture of where and how these new meds worked.

With that in mind we’ve put together a really great edition for you including information on how the kidney filters our blood and how these medications exert their effect.